Revumenib

SI-7183

Revumenib, >98% (HPLC)

CAS No. : [2169919-21-3]

Synonyms : SNDX-5613

IUPAC Name : N-Ethyl-2-((4-(7-(((1r,4r)-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Revumenib potently and selectively inhibits the Menin–MLL interaction (K_i = 0.149 nM; cell IC₅₀ = 10–20 nM) and is widely used to study the biology and therapeutic targeting of MLL‑rearranged ALL and AML.

References : Fiskus W. et al.: Blood Cancer J. 12(1), 5, 2022.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.